Do the downloads!! Share!! The diffusion of very important information and knowledge is essential for the world progress always!! Thanks!!
- – > Mestrado – Dissertation – Tabelas, Figuras e Gráficos – Tables, Figures and Graphics – ´´My´´ Dissertation @ #Innovation #energy #life #health #Countries #Time #Researches #Reference #Graphics #Ages #Age #Mice #People #Person #Mouse #Genetics #PersonalizedMedicine #Diagnosis #Prognosis #Treatment #Disease #UnknownDiseases #Future #VeryEfficientDrugs #VeryEfficientVaccines #VeryEfficientTherapeuticalSubstances #Tests #Laboratories #Investments #Details #HumanLongevity #DNA #Cell #Memory #Physiology #Nanomedicine #Nanotechnology #Biochemistry #NewMedicalDevices #GeneticEngineering #Internet #History #Science #World
The influence of physical activity in the progression of experimental lung cancer in mice
- PMID: 22683274
- DOI: 10.1016/j.prp.2012.04.006
GRUPO_AF1 – GROUP AFA1 – Aerobic Physical Activity – Atividade Física Aeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
GRUPO AFAN 1 – GROUP AFAN1 – Anaerobic Physical Activity – Atividade Física Anaeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
GRUPO_AF2 – GROUP AFA2 – Aerobic Physical Activity – Atividade Física Aeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
GRUPO AFAN 2 – GROUP AFAN 2 – Anaerobic Physical Activity – Atividade Física Anaeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
Slides – mestrado – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
DMBA CARCINOGEN IN EXPERIMENTAL MODELS
Avaliação da influência da atividade física aeróbia e anaeróbia na progressão do câncer de pulmão experimental – Summary – Resumo – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto
Lung cancer is one of the most incident neoplasms in the world, representing the main cause of mortality for cancer. Many epidemiologic studies have suggested that physical activity may reduce the risk of lung cancer, other works evaluate the effectiveness of the use of the physical activity in the suppression, remission and reduction of the recurrence of tumors. The aim of this study was to evaluate the effects of aerobic and anaerobic physical activity in the development and the progression of lung cancer. Lung tumors were induced with a dose of 3mg of urethane/kg, in 67 male Balb – C type mice, divided in three groups: group 1_24 mice treated with urethane and without physical activity; group 2_25 mice with urethane and subjected to aerobic swimming free exercise; group 3_18 mice with urethane, subjected to anaerobic swimming exercise with gradual loading 5-20% of body weight. All the animals were sacrificed after 20 weeks, and lung lesions were analyzed. The median number of lesions (nodules and hyperplasia) was 3.0 for group 1, 2.0 for group 2 and 1.5-3 (p=0.052). When comparing only the presence or absence of lesion, there was a decrease in the number of lesions in group 3 as compared with group 1 (p=0.03) but not in relation to group 2. There were no metastases or other changes in other organs. The anaerobic physical activity, but not aerobic, diminishes the incidence of experimental lung tumors.
Copyright © 2012 Elsevier GmbH. All rights reserved.
Innovative Research Solutions for Mice & Rats
Kent Scientific provides integrated, modular solutions for small animal pre-clinical research and drug discovery advancement. Select a system type or search our products to find the right Kent Scientific solution for your lab.
- AnesthesiaLearn More
- Pulse Oximetry and Heart RateLearn More
- Noninvasive Blood PressureLearn More
- Automatic VentilationLearn More
- Warming and Temperature ControlLearn More
- End-Tidal CO2Learn More
An innovative low-flow anesthesia system that is safe for you and safer for your animals
A physiological monitoring system you configure to meet your research needs
A non-invasive, high throughput system for measuring blood pressure
Additional Featured Products
Visit here often to learn about Kent Scientific products in use, FAQs, whitepaper validations, research partners and moreLearn More
Catch us at Experimental Biology 2019
April 6 – 9, 2019: Orlando, FL
Check out or newest products and speak to a specialist to see how Kent Scientific’s solutions may be right for your research.See Event Details
Building a Better Research Mouse 3/25/2019 Read More
Proudly supporting the research community through product giveaways, travel awards and the sponsorship of professional conferences, meetings and educational programs.Learn More
- Physiological Monitoring
- Noninvasive Blood Pressure
- Rodent Identification
- Animal Handling
- Syringe Pump
Kent Scientific Corporation
1116 Litchfield Street
Torrington, CT 06790, USA Toll Free: (888) 572-8887
Local: (860) 626-1172
Fax: (860) 626-1179Web Solutions © 2006 – 2019 Kent Scientific Corporation. All rights reserved.
Promissora, técnica Crispr é aplicada pela 1ª vez em pacientes com câncer
Crispr Therapeutics e sua parceira Vertex Pharmaceuticals lideram a corrida da edição genética
Por Tatiana Darie, da Bloombergaccess_time 17 abr 2019, 10h12 more_horiz
Crispr: técnica de edição genética começa a ser testada no tratamento de câncer (sxc.hu/Reprodução)
Médicos do Centro de Câncer Abramson, da Universidade da Pensilvânia, realizaram uma infusão com um medicamento à base de Crispr em dois pacientes com câncer, em outro teste em humanos com a promissora tecnologia de edição de genes.
Ambos os pacientes com câncer haviam tido uma recaída antes do início do estudo clínico. Um paciente tem mieloma múltiplo e, o outro, sarcoma, disse o representante da Penn Medicine, John Infanti, em e-mail. O teste clínico é financiado pelo Instituto Parker de Imunoterapia para o Câncer, do bilionário Sean Parker, e pela empresa de capital fechado Tmunity Therapeutics, disse.